Suboptimal medication management is the biggest driver of cost, unrealized treatment goals, poor treatment outcomes, and mortality in the United States, representing $528 Billion in costs – roughly 15% of total US healthcare spend.
With clinical and financial outcomes at stake, innovative health care systems and providers are investing in new solutions and strategies to address issues with suboptimal medication management, including investing in telepharmacy.
During this webinar, Michael Ross, MD, MHA, Chief Medical Officer, Cureatr and Mike Case Haub, CEO at CHC Health discuss how telepharmacy is fast becoming a viable option for delivering medication management services in a way that’s convenient for patients, improves clinical outcomes, and reduces costs.
The webinar covers:
© Cureatr 2022
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).